Staphylococcus aureus Lipase 1 Enhances Influenza A Virus Replication

Area of Science:

• Virology and Microbiology
• Infectious Diseases
• Biochemistry

Background:

• Influenza A virus (IAV) causes significant annual epidemics and pandemics.
• Secondary bacterial coinfections, particularly with Staphylococcus aureus, complicate IAV infections, increasing morbidity and mortality.
• Understanding host-pathogen interactions is crucial for developing effective treatments and vaccines.

Purpose of the Study:

• To identify bacterial factors from Staphylococcus aureus that influence influenza A virus replication.
• To investigate the mechanism by which Staphylococcus aureus lipase 1 affects IAV.
• To explore the potential of lipase 1 in enhancing influenza vaccine production.

Main Methods:

• In vitro replication assays using primary human lung fibroblasts.
• Enzymatic activity assays to determine lipase 1's functional role.
• In vivo infection models using embryonated hen's eggs.

Main Results:

• Staphylococcus aureus secreted protein lipase 1 was identified as enhancing IAV replication.
• Lipase 1's proviral activity is dependent on its enzymatic function and acts late in the viral life cycle, specifically by modulating virus budding.
• Lipase 1 significantly increased IAV yield in vivo, with a 5-fold enhancement observed for a vaccine strain.

Conclusions:

• Lipase 1 is the first identified Staphylococcus aureus protein that enhances IAV replication.
• The mechanism involves the positive modulation of virus budding, increasing viral infectivity.
• This finding suggests a potential role for lipase 1 in IAV-bacterial coinfections and offers a novel strategy for boosting influenza vaccine yields.